Formula Growth’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-34,722
Closed -$473K – 155
2022
Q4
$473K Hold
34,722
– – 0.13% 123
2022
Q3
$481K Hold
34,722
– – 0.14% 119
2022
Q2
$499K Hold
34,722
– – 0.14% 117
2022
Q1
$785K Hold
34,722
– – 0.15% 127
2021
Q4
$652K Hold
34,722
– – 0.12% 128
2021
Q3
$1.14M Hold
34,722
– – 0.16% 127
2021
Q2
$1.48M Hold
34,722
– – 0.2% 119
2021
Q1
$1.33M Sell
34,722
-5,000
-13% -$213K 0.19% 133
2020
Q4
$1.74M Hold
39,722
– – 0.29% 91
2020
Q3
$1.56M Hold
39,722
– – 0.29% 99
2020
Q2
$1.25M Hold
39,722
– – 0.21% 100
2020
Q1
$1.4M Sell
39,722
-10,000
-20% -$422K 0.27% 84
2019
Q4
$2.42M Hold
49,722
– – 0.3% 79
2019
Q3
$2.36M Hold
49,722
– – 0.35% 73
2019
Q2
$2.13M Hold
49,722
– – 0.3% 79
2019
Q1
$1.92M Hold
49,722
– – 0.27% 83
2018
Q4
$1.42M Hold
49,722
– – 0.23% 86
2018
Q3
$1.95M Hold
49,722
– – 0.22% 88
2018
Q2
$1.61M Hold
49,722
– – 0.18% 104
2018
Q1
$1.09M Hold
49,722
– – 0.13% 130
2017
Q4
$1.18M Sell
49,722
-15,000
-23% -$378K 0.15% 109
2017
Q3
$1.82M Sell
64,722
-2,478
-4% -$75.4K 0.29% 84
2017
Q2
$2.17M Hold
67,200
– – 0.37% 66
2017
Q1
$1.9M Buy
67,200
+7,500
+13% +$199K 0.4% 76
2016
Q4
$1.45M Sell
59,700
-20,000
-25% -$491K 0.34% 87
2016
Q3
$1.89M Hold
79,700
– – 0.43% 80
2016
Q2
$1.46M Hold
79,700
– – 0.36% 95
2016
Q1
$826K Sell
79,700
-3,300
-4% -$33.4K 0.2% 127
2015
Q4
$1.25M Buy
+83,000
New +$1.23M 0.29% 106

Other funds holding CSII

Formula Growth's CSII Position: Q1 2023 in Review

Formula Growth sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 34,722 shares — an estimated $473K sold.

Formula Growth first reported a position in CSII in Q4 2015 and held it in 29 quarters. The position peaked at $2.42M in Q4 2019. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • Formula Growth reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • Formula Growth sold 34,722 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $473K.
  • Formula Growth first reported a position in Cardiovascular Systems, Inc. in Q4 2015 and held it in 29 quarters.
  • Formula Growth's Cardiovascular Systems, Inc. position peaked at $2.42M in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Formula Growth's 13F filing for Q1 2023, filed 12 May 2023.